On Thursday, Prince Harry took bioLytical’s 60-second INSTI HIV antibody test at London-based Guy and St. Thomas’ Hospital during a live broadcasting on the royal family’s Facebook page.
The Canadian-based company’s INSTI test produces results with 99 percent accuracy, requiring a single drop of blood from the patient. The test will be available online and in various retail locations by the end of the year, offering patients the opportunity to complete the test in the comfort of their own homes.
“Prince Harry believes until everyone feels relaxed about taking HIV tests — whether from high risk groups or not — then tackling the stigma and fear surrounding HIV testing will continue to allow the virus to win,” according to a statement from Kensington Palace.
Prince Harry’s test results were negative.
More articles on supply chain:
5 latest FDA approvals
Drugmakers have firm grasp on drug pricing power
Drug shortages force workarounds in Conn. hospitals
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.